CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

incb040093

Small moleculeexperimental

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1

1

Phase 2

1

Phase 3

0

Phase 4

0

Earliest trial started Jun 1, 2013 (NCT01905813)

Timeline

2010s

Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Jan 1, 2015
Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

PI3-kinase p110-delta subunitINHIBITOR
PIK3CD inhibitor
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL3545205 ↗
ChEMBLCHEMBL3545054 ↗

Also known as

incb040093
incb040093
incb-040093
incb-40093

Clinical trials

NCT ID	Phase	Start date	Sponsor(s)
NCT02456675	Phase 2	Jun 1, 2015	Incyte
NCT01905813	Phase 1	Jun 1, 2013	Incyte

Showing 2 of 2 trials

Page 1 / 1

Organizations

Research & Development (1)

Organization	Org type	Trials	As lead sponsor	Phases	Earliest year
Incyte	For profit	2	2	2	2013

1 organizations

Page 1 / 1